Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients

Phase 4UnknownNCT01981083

Centro Medico Lic Adolfo Lopez Mate60 enrolled

Overview

Malnutrition is seen frequently in hemodialysis units in most developing countries. Malnutrition increases morbidity and mortality in this population and its treatment improves patient survival and health status The purpose of this study is to compare two strategies to improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml) versus egg albumin-based protein supplement (30 g) on a daily basis. This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment (SGA) in addition to most used biochemical markers to determine nutritional status.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Protein-Energy Malnutrition Kidney Failure, Chronic Hemodialysis

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Chronic Kidney Disease in Hemodialysis Exclusion Criteria: * Infection * Liver insufficiency * Cancer or neoplasia * Acquired immunodeficiency syndrome * Intestinal malabsorption syndrome

Locations (1)

Centro Medico Lic. Adolfo López Mateos

Toluca, State of Mexico, Mexico

Outcomes

Primary Outcomes

Change in Malnutrition-Inflammation Score

Time frame: Bimonthly, up to six months

Change in Subjective Global Assessment

Time frame: Bimonthly, up to six months

Central Contacts

Rafael Gonzalez-Toledo, MD

CONTACT

52(722)2760860 rtoledo29@yahoo.com.mx

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.